Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6189763 | Brachytherapy | 2013 | 6 Pages |
Abstract
Prostate IMRT plus HDR brachytherapy boost was well tolerated with appropriate PSA response and bDFS at 4 years, demonstrated in a community setting. This treatment schema provides a high BED, comparable with hypofractionated prostate regimens previously reported in the literature. Higher BED delivery should be explored in further dose escalation studies.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
William C. Chen, Kenneth M. Tokita, John Ravera, Pingfu Fu, Ying Jiang, Deborah A. Kaminsky, Lee Ponsky, Rodney J. Ellis,